Avotermin Completed Phase 2 Trials for Promotion of wound healing / Cicatrix Treatment

Back to Avotermin
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00984503Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites